Back to Infectious Disease
Infectious Diseasev2.0Evidence-Based

Veterans Aging Cohort Study (VACS) 2.0 Index

Estimates 5-year all-cause mortality risk in patients with HIV using age, HIV-specific biomarkers, and general health indicators. An improved version of the original VACS Index with enhanced discrimination.

Clinical Input Parameters

years
Range: 18 — 100 years
cells/μL
Range: 0 — 2000 cells/μL
log10 copies/mL
Range: 0 — 7 log10 copies/mL
g/dL
Range: 5 — 20 g/dL
×10³/μL
Range: 10 — 1000 ×10³/μL
U/L
Range: 10 — 500 U/L
U/L
Range: 10 — 500 U/L
mg/dL
Range: 0.5 — 10 mg/dL
g/dL
Range: 1 — 6 g/dL
×10³/μL
Range: 1 — 50 ×10³/μL
kg/m²
Range: 10 — 50 kg/m²
Clinical Assessment
Awaiting Parameters
vacs 2 0 score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Veterans Aging Cohort Study (VACS) 2.0 Index is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within infectious disease.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

VACS 2.0 = f(Age, CD4, HIV RNA, Hemoglobin, FIB-4, eGFR, Albumin, WBC, BMI, HCV) where FIB-4 = (Age × AST) / (Platelets × √ALT) and eGFR calculated using CKD-EPI equation

Clinical Pearls & Practice Notes

  • An update to the original VACS Index with improved discrimination
  • Incorporates albumin, WBC count, and BMI for enhanced prognostic accuracy
  • Validated in multiple international cohorts of HIV-positive individuals
  • Higher scores indicate greater disease burden and mortality risk
  • Useful for clinical decision-making and patient counseling
  • Score ranges from 0-164 points, with 80% of patients scoring 0-50 points
  • Mortality risk approximately doubles for every 10-unit increase in score
  • Should be used in conjunction with clinical judgment and other prognostic factors
  • Particularly useful for determining benefit of preventative screening and interventions

Evidence & Literature Citations

  1. Justice AC, Lasky E, McGinnis KA, et al. Medical disease and alcohol use among veterans with human immunodeficiency virus infection: A comparison of disease measurement strategies. Med Care. 2006;44(8 Suppl 2):S52-60.
  2. Justice AC, McGinnis KA, Skanderson M, et al. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med. 2010;11(2):143-51.
  3. Tate JP, Justice AC, Hughes MD, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013;27(4):563-72.
  4. Justice AC, Erlandson KM, Hunt PW, et al. Development and validation of a prognostic index for 1-year mortality in HIV-infected adults. Med Care. 2013;51(12):1054-64.
  5. Rodriguez-Barradas MC, Tate JP, Justice AC, et al. Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals. AIDS. 2019;33(6):903-912.

Score Interpretation Ranges

Low Risk0 – 25 pts

Low 5-year mortality risk

Moderate Risk26 – 50 pts

Moderate 5-year mortality risk

High Risk51 – 75 pts

High 5-year mortality risk

Very High Risk76 – 164 pts

Very high 5-year mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.